当前位置：药药网 / 药品研发 / 美国药品上市后承诺数据库
HEPLISAV-B, Hepatitis B Vaccine (Recombinant), Adjuvanted
申请企业
Dynavax Technologies Corporation
药品名称
HEPLISAV-B, Hepatitis B Vaccine (Recombinant), Adjuvanted
承诺描述
To conduct the following study: “Post-Marketing Observational Surveillance ofthe Safety of HEPLISAV-B in Adults 18 Years of Age and Older to Evaluate theIncidence of New Onset Immune-mediated Diseases, Herpes Zoster, andAnaphylaxis.”